Search

Your search keyword '"Shirai, Shintaro"' showing total 43 results
Start Over Author "Shirai, Shintaro"
43 results on '"Shirai, Shintaro"'

22. Differentiation of Pancreatic Serous Cystadenoma From Endocrine Tumor and Intraductal Papillary Mucinous Neoplasm Based on Washout Pattern on Multiphase CT

Author

Sahara, Shinya, primary, Kawai, Nobuyuki, additional, Sato, Morio, additional, Ikoma, Akira, additional, Minamiguchi, Hiroki, additional, Nakai, Motoki, additional, Sanda, Hiroki, additional, Nakata, Kouhei, additional, Takeuchi, Taizou, additional, Tanaka, Takami, additional, Shirai, Shintaro, additional, and Sonomura, Tetsuo, additional

Published
2012
Full Text
View/download PDF

23. Distribution of Functional Liver Volume in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus in the 1st Branch and Main Trunk Using Single Photon Emission Computed Tomography—Application to Radiation Therapy

Author

Shirai, Shintaro, primary, Sato, Morio, additional, Noda, Yasutaka, additional, Kishi, Kazushi, additional, Kawai, Nobuyuki, additional, Minamiguchi, Hiroki, additional, Nakai, Motoki, additional, Sanda, Hiroki, additional, Sahara, Shinya, additional, Ikoma, Akira, additional, and Sonomura, Tetsuo, additional

Published
2011
Full Text
View/download PDF

27. QUALITY OF LIFE ANALYSIS OF PATIENTS WHO UNDERWENT HIGH DOSE RATE BRACHYTHERAPY WITH EXTERNAL BEAM RADIOTHERAPY (HDR+EBRT) COMPARING WITH THOSE WHO HAD RETROPUBIC RADICAL PROSTATECTOMY (RRP)

Author

Inagaki, Takeshi, primary, Kohjimoto, Yasuo, additional, Mori, Takashi, additional, Kuramoto, Tomomi, additional, Nishizawa, Satoshi, additional, Fujii, Reona, additional, Nampo, Yoshihito, additional, Matsumura, Nagahide, additional, Shintani, Yasuyo, additional, Shirai, Shintaro, additional, Sato, Morio, additional, and Hara, Isao, additional

Published
2009
Full Text
View/download PDF

32. Eradicative brachytherapy with hyaluronate gel injection into pararectal space in treatment of bulky vaginal stump recurrence of uterine cancer

Author

Kishi, Kazushi, Mabuchi, Yasushi, Sonomura, Tetsuo, Shirai, Shintaro, Noda, Yasutaka, Sato, Morio, and Ino, Kazuhiko

Abstract

The purpose of this study is to develop a procedure for eradicative brachytherapy that can deliver a curative boost dose to bulky (>4 cm) vaginal stump recurrence of uterine cancer without risk of damaging surrounding organs. We separated risk organs (the rectum and sigmoid) from the target during brachytherapy, with a hyaluronate gel injection into the pararectal space via the percutaneous paraperineal approach under local anesthesia. The rectum anchored to the sacrum by native ligament was expected to shift posteriorly. We encountered a patient with bulky stump recurrence of uterine cancer, approximately 8 cm in maximum diameter. She was complaining of abdominal pain and constipation due to bowel encasement. Following 50 Gy of external beam radiotherapy, we applied a single fraction of brachytherapy under gel separation and delivered 14.5 Gy (50.8 GyE: equivalent dose in 2-Gy fraction calculated with linear quadratic model at a/ß = 3) to the target. The gel injection procedure was completed in 30 min without complications. A total irradiation dose of 100.8 GyE was delivered to the target and the cumulative minimum dose to the most irradiated rectosigmoidal volume of 2 cc (cumulative D2cc) was calculated as 58.5 GyE with gel injection, and was estimated to be 96 GyE without. Over three years, the local stump tumor has completely disappeared, with no complications. Brachytherapy with a pararectal gel injection can be a safe and effective eradicative option for bulky vaginal stump recurrence.

Published
2012
Full Text
View/download PDF

36. The Role of Antineoplastic Solution in Transcatheter Hepatic Arterial Embolization

Author

ツダ, マサヒロ, サトウ, モリオ, カワバタ, マモル, シライ, シンタロウ, タナカ, カヨ, テラダ, マサキ, シオヤマ, ヤスカズ, マエダ, ミホ, キシ, カズシ, スワ, カズヒロ, ヨシカワ, アキテル, カワハラ, キミコ, ミツザネ, キヨシ, ヤマダ, リュウサク, Tsuda, Masahiro, Sato, Morio, Kawabata, Mamoru, Shirai, Shintaro, Tanaka, Kayo, Terada, Masaki, Shioyama, Yasukazu, Maeda, Miho, Kishi, Kazushi, Suwa, Kazuhiro, Yoshikawa, Akiteru, Kawahara, Kimiko, Mitsuzane, Kiyoshi, Yamada, Ryusaku, 津田, 正洋, 佐藤, 守男, 川端, 衛, 白井, 信太郎, 田中, 佳代, 寺田, 正樹, 塩山, 靖和, 前田, 美穂, 岸, 和史, 諏訪, 和宏, 吉川, 明輝, 川原, 公子, 光實, 淳, 山田, 龍作, ツダ, マサヒロ, サトウ, モリオ, カワバタ, マモル, シライ, シンタロウ, タナカ, カヨ, テラダ, マサキ, シオヤマ, ヤスカズ, マエダ, ミホ, キシ, カズシ, スワ, カズヒロ, ヨシカワ, アキテル, カワハラ, キミコ, ミツザネ, キヨシ, ヤマダ, リュウサク, Tsuda, Masahiro, Sato, Morio, Kawabata, Mamoru, Shirai, Shintaro, Tanaka, Kayo, Terada, Masaki, Shioyama, Yasukazu, Maeda, Miho, Kishi, Kazushi, Suwa, Kazuhiro, Yoshikawa, Akiteru, Kawahara, Kimiko, Mitsuzane, Kiyoshi, Yamada, Ryusaku, 津田, 正洋, 佐藤, 守男, 川端, 衛, 白井, 信太郎, 田中, 佳代, 寺田, 正樹, 塩山, 靖和, 前田, 美穂, 岸, 和史, 諏訪, 和宏, 吉川, 明輝, 川原, 公子, 光實, 淳, and 山田, 龍作

Published
1987

37. Short Term Intraarterial Infusion with Ultrahigh-Dose Urokinase in Treatment of Peripheral Arterial Occlusive disease

Author

サトウ, モリオ, テラダ, マサキ, ミツザネ, キヨシ, スワ, カズヒロ, ヨシカワ, アキテル, キシ, カズシ, シライ, シンタロウ, マエダ, ミホ, シオヤマ, ヤスカズ, ツダ, マサヒロ, ノムラ, ショウゾウ, マエダ, チカヒコ, カワバタ, マモル, ミシマ, タカオ, ヤマダ, リュウサク, Sato, Morio, Terada, Masaki, Mitsuzane, Kiyoshi, Suwa, Kazuhiro, Yoshikawa, Akiteru, Kishi, Kazushi, Shirai, Shintaro, Maeda, Miho, Shioyama, Yasukazu, Tsuda, Masahiro, Nomura, Syozo, Maeda, Chikahiko, Kawabata, Mamoru, Mishima, Takao, Yamada, Ryusaku, 佐藤, 守男, 寺田, 正樹, 光実, 淳, 諏訪, 和宏, 吉川, 明輝, 岸, 和史, 白井, 信太郎, 前田, 美保, 塩山, 靖和, 津田, 正洋, 野村, 尚三, 前田, 親彦, 川端, 衛, 三島, 隆生, 山田, 龍作, サトウ, モリオ, テラダ, マサキ, ミツザネ, キヨシ, スワ, カズヒロ, ヨシカワ, アキテル, キシ, カズシ, シライ, シンタロウ, マエダ, ミホ, シオヤマ, ヤスカズ, ツダ, マサヒロ, ノムラ, ショウゾウ, マエダ, チカヒコ, カワバタ, マモル, ミシマ, タカオ, ヤマダ, リュウサク, Sato, Morio, Terada, Masaki, Mitsuzane, Kiyoshi, Suwa, Kazuhiro, Yoshikawa, Akiteru, Kishi, Kazushi, Shirai, Shintaro, Maeda, Miho, Shioyama, Yasukazu, Tsuda, Masahiro, Nomura, Syozo, Maeda, Chikahiko, Kawabata, Mamoru, Mishima, Takao, Yamada, Ryusaku, 佐藤, 守男, 寺田, 正樹, 光実, 淳, 諏訪, 和宏, 吉川, 明輝, 岸, 和史, 白井, 信太郎, 前田, 美保, 塩山, 靖和, 津田, 正洋, 野村, 尚三, 前田, 親彦, 川端, 衛, 三島, 隆生, and 山田, 龍作

Published
1986

38. Esophageal gel-shifting technique facilitating eradicative boost or reirradiation to upper mediastinal targets of recurrent nerve lymph node without damaging esophagus

Author

Kishi, Kazushi, Iida, Takeshi, Ojima, Toshiyasu, Sonomura, Tetsuo, Shirai, Shintaro, Nakai, Motoki, Sato, Morio, and Yamaue, Hiroki

Abstract

We developed a new technique using hyaluronic gel injection as a spacer to safely move the esophagus away from the high-dose area during interstitial brachytherapy of a mediastinal target close to the esophagus. We percutaneously injected a high-molecular-weight hyaluronic gel mixed with contrast medium to create a space between the esophagus and the target during interstitial brachytherapy. We applied this technique to two cases of relapsed recurrent nerve lymph node metastasis from esophageal cancer: one refractory tumor after 50 Gy of radiotherapy, and one recurrence after mediastinal radiotherapy of total 64 Gy. We prescribed 20 Gy and 18 Gy in one fraction to each target, with calculated esophageal D2cc (the minimum dose to the most irradiated volume of 2 cc) of 4.0 Gy and 6.8 Gy, respectively. Calculated enhancement factor by gel shifting in equivalent dose was 2.69 and 2.34, respectively. In each patient, accumulated esophageal D1cc (minimum dose to the most irradiated volume of p cc. minimum dose to the most irradiated volume of 1 cc) was 74.4 Gy and 85.6 Gy without shifting, and 59.1 Gy and 37.6 Gy with shifting, respectively. There were no procedure-related complications. Four months after the brachytherapy, each tumor was remarkably diminished. No evidence of recurrences or late complications were observed 8 months and 9 months after the procedure, respectively. The esophageal gel-shifting technique may facilitate eradicative brachytherapy to upper mediastinal targets without damaging the esophagus, and can be used in conjunction with boost irradiation or reirradiation to overcome the problem of salvage failure.

Published
2013
Full Text
View/download PDF

39. The 47 ronin. Part 2 = Genroku chushingura

Author

Shōchiku Kabushiki Kaisha. Production company, Criterion Collection (Firm) Distributor, Janus Films. Distributor, Bando, Haranosuke. Actor, Arashi, Tokusaburō, 1933-2000. Actor, Arashi, Yoshisaburō, 1907-1977. Actor, Mizoguchi, Kenji, 1898-1956. Director, and Shirai, Shintarô. Producer

Published
1941

40. The 47 ronin. Part 1 = Genroku chushingura

Author

Criterion Collection (Firm) Distributor, Shōchiku Kabushiki Kaisha. Production company, Janus Films. Distributor, Bando, Haranosuke. Actor, Arashi, Tokusaburō, 1933-2000. Actor, Arashi, Yoshisaburō, 1907-1977. Actor, Mizoguchi, Kenji, 1898-1956. Director, and Shirai, Shintarô. Producer

Published
1941

41. Novel eradicative high-dose rate brachytherapy for internal mammary lymph node metastasis from breast cancer.

Author

Kishi K, Tanino H, Sonomura T, Shirai S, Noda Y, Sato M, and Okamura Y

Abstract

Aim: To develop a method of delivering an eradicative high radiotherapeutic dose safely preserving the surrounding skin in the treatment of internal mammary lymph node metastasis (IMLNM) of breast cancer., Methods: We report a 38-year-old female patient with a solo IMLNM showing no response to 60 Gy in 2.5 Gy fractions of external beam radiotherapy. To eradicate this tumor, a boost brachytherapy plan was created after percutaneous insertion of an applicator needle into the IMLNM lesion avoiding the pleura and vessels under ultrasound monitoring. According to the dose distribution, the required thickness of a spacer between the skin and the tumor was determined, and hyaluronic gel was injected up to this thickness under ultrasound monitoring. We evaluated skin doses, target doses and clinical outcome., Results: All procedures were performed easily. Sixteen Gy (34.7 Gy equivalent in 2 Gy fractions calculated by the linear quadratic model at α/β = 10: EQD(2, α/β = 10), cumulative total was 101.9 Gy EQD10) to 100% of the target volume was irradiated with cumulative maximum skin dose of 70 Gy EQD(2, α/β = 3) which was 98.7 Gy EQD(2, α/β = 3) without spacer. No procedure related- or late complications and no local recurrence at the treated site were observed for three years until expiration., Conclusion: We consider that this procedure will provide an eradicative high-dose irradiation to IMLNM of breast cancer, preserving skin from overdose complications.

Published
2012
Full Text
View/download PDF

42. Evaluation of vascular puncture needles with specific modifications for enhanced ultrasound visibility: In vitro study.

Author

Kawai N, Minamiguchi H, Sato M, Nakai M, Sanda H, Tanaka T, Ikoma A, Nakata K, Shirai S, and Sonomura T

Abstract

Aim: To determine which modification to a vascular puncture needle results in increased visualization during ultrasound (US)-guided vascular puncture., Methods: We evaluated US images of a phantom made of degassed gelatin and each of the following four modified versions of a commercially available vascular puncture needle (18 G): re-cut needle, dimple needle, rough-surface needle (rough over the sections of needle located 3-6 mm from the tip), and a needle with four side holes (side holes covered by the sheath). An unmodified commercially available puncture needle was used as a control. Five interventional radiologists evaluated image quality according to the following classification grade: I, invisible; II, poor; III, moderate; IV, good; V, excellent., Results: The highest score for needle visualization was obtained for the needle with four side holes. The re-cut needle scored the same as the control. Multiple comparisons were conducted using overall evaluation scores among the commercially available needle, dimple needle, rough-surface needle (3-6 mm), and the needle with four side holes. A significantly higher score was obtained for the needle with four side holes (P < 0.05/6)., Conclusion: The needle with four side holes was prominently visualized and gained a significantly higher score (compared with the other needles) in a phantom evaluation.

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results